Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000

Drug and Alcohol Dependence

Volumn 83, Issue 2, 2006, Pages 147-156

  Shah, Nina G ^a   Galai, Noya ^b   Celentano, David D ^b   Vlahov, David ^c   Strathdee, Steffanie A ^d  

^a NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NEW YORK ACADEMY OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cessation; HIV infection; Homelessness; Injection drug use; Methadone maintenance; Relapse

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE;

ADULT; AFRICAN AMERICAN; ALCOHOL WITHDRAWAL; ANALYTICAL PARAMETERS; ARTICLE; BIOLOGICAL MODEL; COCAINE DEPENDENCE; COMMUNITY; CONTROLLED STUDY; DETOXIFICATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH PROGRAM; HOMELESSNESS; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORPHINE ADDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RELAPSE; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUALITY; SMOKING CESSATION; SURVIVAL; UNITED STATES;

ADULT; BALTIMORE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; METHADONE; PATIENT COMPLIANCE; PREVALENCE; RECURRENCE; SMOKING; SMOKING CESSATION; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 33746617377     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2005.11.007     Document Type: Article

References (49)

1. Anthony J.C., Vlahov D., and Nelson K.E. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am. J. Epidemiol. 134 (1991) 1175-1189
2. Avants S.K., Warburton L.A., and Margolin A. How injection drug users coped with testing HIV-seropositive: implications for subsequent health-related behaviors. AIDS Educ. Prev. 13 (2001) 207-218
3. Bammer G., Battison L., Ward J., and Wilson S. The impact of retention of expansion of an Australian public methadone program. Drug Alcohol Depend. 58 (2000) 173-180
4. Belding M.A., Iguchi M.Y., Lamb R.J., Lakin M., and Terry R. Coping strategies and continued drug sue among methadone maintenance patients. Addict. Behav. 21 (1996) 389-401
5. Booth R.E., Crowley T.J., and Zhang Y. Substance abuse treatment entry, retention and effectiveness: out-of-treatment opiate injection drug users. Drug Alcohol Depend. 2 (1996) 11-20
6. Celentano D.D., Vlahov D., Cohn S., Anthony J.C., Solomon L., and Nelson K.E. Risk factors for shooting gallery use and cessation among intravenous drug users. Am. J. Publ. Health 81 (1991) 1291-1295
7. Celentano D.D., Munox A., Cohn S., Nelson K.E., and Vlahov D. Drug-related behavior change for HIV transmission among American injection drug users. Addiction 89 (1994) 1309-1317
8. Colón H.M., Robles R.R., Deren S., Sahai H., Finlinson H.A., Andía J., Cruz M.A., Kang S.Y., and Oliver-Vélez D. Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, NY and Bayamon, PR. J. Acquir. Immune Defic. Syndr. 27 (2001) 405-413
9. Cox D.R., and Snell E.J. Analysis of Survival Data (1968), Chapman & Hall, London
10. DiNitto D.M., Webb D.K., and Rubin A. Gender differences in dually-diagnosed clients receiving chemical dependency treatment. J. Psychoactive Drugs 34 (2002) 105-117
11. Doherty M.C., Garfein R.S., Monterroso E., Brown D., and Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS 14 (2000) 717-726
12. Friedman S., Curtis R., Neaigus A., Jose B., and Des Jarlais D. Social Networks, Drug Injectors' Lives and HIV/AIDS (1999), Kluwer Academic, New York
13. Galai N., Safaeian M., Vlahov D., Bolotin A., Celentano D.D., and ALIVE Study. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988-2000: description and determinants. Am. J. Epidemiol. 158 (2003) 695-704
14. Garfein R.S., Vlahov D., Galai N., Doherty M.C., and Nelson K.E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am. J. Publ. Health 86 (1996) 655-661
15. Goldstein M.F., Deren S., Magura S., Kayman D.J., Beardsley M., and Tortu S. Cessation of drug use: impact of time in treatment. J. Psychoactive Drugs 32 (2000) 305-310
16. Gossop M., Marsden J., Stewart D., and Treacy S. Change and stability of change after treatment of drug misuse: 2-year outcomes from the National Treatment Outcome Research Study (UK). Addict. Behav. 27 (2002) 155-166
17. Hartel D.M., and Schoenbaum E.E. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Publ. Health Rep. 113 (1998) 107-113
18. Harwood H.J., Fountain D., and Fountain G. Economic cost of alcohol and drug abuse in the United States, 1992. Addiction 94 (1992) 631-635
19. Hemby S.E., Co C., Dworkin S.I., and Smith J.E. Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of heroin/cocaine combinations (speedballs) in rats. J. Pharmacol. Exp. Ther. 288 (1999) 274-280
20. Hosmer Jr. D.W., and Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data (1999), John Wiley and Sons, New York
21. Johnson R.A., Gerstein D.R., Pach III A., Cerbone F.G., and Brown J. HIV risk behaviors in African-American drug injector networks: implications of injection-partner mixing and partnership characteristics. Addiction 97 (2002) 1011-1024
22. Joseph H., Stancliff S., and Landgrod J. Methadone maintenance treatment (MTT): a review of historical and clinical issues. Mt. Sinai J. Med. 67 (2000) 347-364
23. Kwiatkowski C.F., and Booth R.E. Methadone maintenance as HIV risk reduction with street-recruited injecting drug users. J. Acquir. Immune Defic. Syndr. 26 (2001) 483-489
24. Langendam M.W., Van Brussel G.H.A., Coutinho R.A., and van Ameijden E.J.C. Methadone maintenance and cessation of injection drug use: results from the Amsterdam cohort study. Addiction 95 (2000) 591-600
25. Latkin C.A., Vlahov D., and Anthony J.C. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 88 (1993) 517-526
26. Latkin C.A., Knowlton A.R., Hoover D., and Mandell W. Drug network characteristics as a predictor of cessation of drug use among adult injection drug users: a prospective study. Am. J. Drug Alcohol Abuse 25 (1999) 463-473
27. Lewis D.C. Access to narcotic addiction treatment and medical care: prospects for the expansion of methadone maintenance treatment. J. Addict. Dis. 18 (1999) 5-21
28. Lundy A., Gottheil E., Serota R.D., Weinstein S.P., and Sterling R.C. Gender differences and similarities in African American crack cocaine abusers. J. Nerv. Ment. Dis. 183 (1995) 260-266
29. McElrath K., Chitwood D.D., Griffin D.K., and Comerford M. The consistency of self-reported HIV risk behavior among injection drug users. Am. J. Publ. Health 84 (1994) 1965-1970
30. Metzger D.S., and Navaline H. HIV prevention among injection drug users: the need for integrated models. J. Urban Health 80 4 Suppl. 3 (2003) iii.59-iii.66
31. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA 280 (1998) 1936-1943
32. Raisch D.W., Fye C.L., Boardman K.D., and Sather M.R. Opioid dependence treatment, including buprenorphine/naloxone. Ann. Pharmacother. 36 (2002) 312-321
33. Rehm J., Gschwend P., Steffen T., Gutzwiller F., Dobler-Mikola A., and Uchtenhagen A. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 358 (2001) 1417-1420
34. Safaeian M., Brookmeyer R., Vlahov D., Latkin C., Marx M., and Strathdee S.A. Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation. Am. J. Epidemiol. 155 (2001) 169-175
35. Schroeder J.R., Latkin C.A., Hoover D.R., Curry A.D., Knowlton A.R., and Celentano D.D. Illicit drug use in one's social network and in one's neighborhood predicts individual heroin and cocaine use. Ann. Epidemiol. 11 (2001) 389-394
36. Shah N.G., Celentano D.D., Vlahov D., Stambolis V., Johnson L., Nelson K.E., and Strathdee S.A. Correlates of enrolment in methadone maintenance treatment programs differ by HIV-serostatus. AIDS 14 (2000) 2035-2043
37. Shore R.E., Marmor M., Titus S., and Des Jarlais D.C. Methadone maintenance and other factors associated with intraindividual temporal trends in injection-drug use. J. Subst. Abuse Treat. 13 (1996) 241-248
38. Sibthorpe B., and Lear B. Circumstances surrounding needle use transitions among injection drug users: implications for HIV intervention. Int. J. Addict. 29 (1994) 1245-1257
39. Simpson D.D. Treatment for drug abuse. Follow-up outcome and length of time spent. Arch. Gen. Psychiatr. 38 (1981) 875-880
40. Simpson D.D., and Joe G.W. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 30 (1993) 357-367
41. Simpson D.D., Joe G.W., and Rowan-Szal G.A. Drug abuse treatment and process effects on follow-up outcomes. Drug Alcohol Depend. 47 (1997) 227-235
42. Song J.Y., Safaeian M., Strathdee S.A., Vlahov D., and Celentano D.D. The prevalence of homelessness among injection drug users with and without HIV infection. J. Urban Health 77 (2000) 678-687
43. Stimson G.V., Adelekan M., and Rhodes T. The diffusion of drug injecting in developing countries. Int. J. Drug Policy 7 (1996) 245-255
44. Sullivan L.E., Metzger D.S., Fudala P.J., and Fiellin D.A. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction 100 (2005) 150-158
45. Toumbourou J.W., Hamilton B., and Fallon B. Treatment level progress and time spent in treatment in the prediction of outcomes following drug-free therapeutic community treatment. Addiction 93 (1998) 1054-1064
46. van Ameijden E.J.C., and Coutinho R.A. Maximum impact of HIV prevention measures targeted at injection drug user. AIDS 12 (1998) 625-633
47. van Ameijden E.J.C., and Coutinho R.A. Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions. J. Epidemiol. Community Health 55 (2001) 356-363
48. Vlahov D., Anthony J.C., Munoz A., Margolick J., Nelson K.E., Celentano D.D., Solomon L., and Polk B.F. The ALIVE Study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res. Monogr. 109 (1991) 75-100
49. Warner L.A., Alegria M., and Canino G. Remission from drug dependence symptoms and drug use cessation among women drug users in Puerto Rico. Arch. Gen. Psychiatr. 61 (2004) 1034-1041